C. Rusconi

1.4k total citations
18 papers, 516 citations indexed

About

C. Rusconi is a scholar working on Pathology and Forensic Medicine, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, C. Rusconi has authored 18 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 6 papers in Genetics and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in C. Rusconi's work include Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Multiple Myeloma Research and Treatments (4 papers). C. Rusconi is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Multiple Myeloma Research and Treatments (4 papers). C. Rusconi collaborates with scholars based in Italy, United States and United Kingdom. C. Rusconi's co-authors include Pompilio Faggiano, Tony Sabatini, Gerard P. Aurigemma, William H. Gaasch, Patrizia Zappasodi, Alessandro Corso, Silvia Mangiacavalli, Mario Lazzarino, Marzia Varettoni and Michele Spina and has published in prestigious journals such as The American Journal of Cardiology, Annals of Oncology and American Heart Journal.

In The Last Decade

C. Rusconi

17 papers receiving 496 citations

Peers

C. Rusconi
Jinglan Pei United States
Marie Bretagne France
Ghandi Damaj France
María Teresa Santarelli Argentina
Hans-Martin Otten Netherlands
A. Karabelis Greece
G. A. T. Hawson Australia
Claudia Parolini Italy
Lee Chun Park South Korea
G. Lukina Russia
Jinglan Pei United States
C. Rusconi
Citations per year, relative to C. Rusconi C. Rusconi (= 1×) peers Jinglan Pei

Countries citing papers authored by C. Rusconi

Since Specialization
Citations

This map shows the geographic impact of C. Rusconi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Rusconi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Rusconi more than expected).

Fields of papers citing papers by C. Rusconi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Rusconi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Rusconi. The network helps show where C. Rusconi may publish in the future.

Co-authorship network of co-authors of C. Rusconi

This figure shows the co-authorship network connecting the top 25 collaborators of C. Rusconi. A scholar is included among the top collaborators of C. Rusconi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Rusconi. C. Rusconi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Launonen, Aino, et al.. (2019). CLINICAL OUTCOMES OF PATIENTS WITH INTERMEDIATE‐TO‐HIGH‐RISK FOLLICULAR LYMPHOMA (FL) IN THE GALLIUM PHASE III STUDY. Hematological Oncology. 37(S2). 386–387. 1 indexed citations
2.
Rule, Simon, Wojciech Jurczak, Mats Jerkeman, et al.. (2018). Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study. Leukemia. 32(8). 1799–1803. 72 indexed citations
3.
Rule, Simon, Wojciech Jurczak, Mats Jerkeman, et al.. (2017). IBRUTINIB VS TEMSIROLIMUS: THREE‐YEAR FOLLOW‐UP OF PATIENTS WITH PREVIOUSLY TREATED MANTLE CELL LYMPHOMA FROM THE PHASE 3, INTERNATIONAL, RANDOMIZED, OPEN‐LABEL RAY STUDY. Hematological Oncology. 35(S2). 143–144. 2 indexed citations
4.
Rossi, Davide, Alessio Bruscaggin, Sara Galimberti, et al.. (2015). The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study. Haematologica. 100(4). 517–524. 4 indexed citations
5.
Luminari, Stefano, Irène Biasoli, Luca Arcaini, et al.. (2013). The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi. Annals of Oncology. 24(8). 2108–2112. 110 indexed citations
6.
Zaja, Francesco, Stefania De Luca, Umberto Vitolo, et al.. (2011). Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers. Haematologica. 97(3). 416–422. 52 indexed citations
7.
Arcaini, Luca, Daniele Vallisa, Michele Merli, et al.. (2011). Hematological response to antiviral treatment in 94 patients with indolent B-cell lymphomas associated with hepatitis C virus infection : a study of the Fondazione Italiana Linfomi (FIL). 22. 129–129. 4 indexed citations
8.
Pallavicini, Marco, Laura Fumagalli, Marco Gobbi, et al.. (2006). QSAR study for a novel series of ortho disubstituted phenoxy analogues of α1-adrenoceptor antagonist WB4101. European Journal of Medicinal Chemistry. 41(9). 1025–1040. 22 indexed citations
9.
Corso, Alessandro, Silvia Mangiacavalli, Annamaria Nosari, et al.. (2005). Efficacy, toxicity and feasibility of a shorter schedule of DCEP regimen for stem cell mobilization in multiple myeloma. Bone Marrow Transplantation. 36(11). 951–954. 5 indexed citations
10.
Corso, Alessandro, Marzia Varettoni, Silvia Mangiacavalli, et al.. (2004). Modification of thrombomodulin plasma levels in refractory myeloma patients during treatment with thalidomide and dexamethasone. Annals of Hematology. 83(9). 588–91. 58 indexed citations
11.
Corso, Alessandro, Patrizia Zappasodi, Cristiana Pascutto, et al.. (2003). Urinary proteins in multiple myeloma: correlation with clinical parameters and diagnostic implications. Annals of Hematology. 82(8). 487–491. 18 indexed citations
12.
Rusconi, C.. (2000). [Diastolic function of the left ventricle and congestive heart failure with normal systolic function].. PubMed. 1(10). 1273–80. 2 indexed citations
13.
Faggiano, Pompilio, Gerard P. Aurigemma, C. Rusconi, & William H. Gaasch. (1996). Progression of valvular aortic stenosis in adults: Literature review and clinical implications. American Heart Journal. 132(2). 408–417. 60 indexed citations
14.
Rusconi, C., et al.. (1996). Congestive heart failure due to rapid right ventricular obliteration by metastatic malignant melanoma.. PubMed. 44(3). 123–5. 3 indexed citations
15.
16.
Neuhaus, P., et al.. (1995). [Cardiac metastasis of a hepatocellular carcinoma after liver transplantation].. PubMed. 23(26). 1224–1224.
17.
Caradonna, Eugenio, et al.. (1993). [Primary mesothelioma of the pericardium with long-term survival].. PubMed. 41(6). 269–74. 3 indexed citations
18.
Sabatini, Tony, et al.. (1992). Rate of progression of valvular aortic stenosis in adults. The American Journal of Cardiology. 70(2). 229–233. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinglan Pei Breakdown of academic impact, for papers by Marie Bretagne Breakdown of academic impact, for papers by Ghandi Damaj Breakdown of academic impact, for papers by María Teresa Santarelli Breakdown of academic impact, for papers by Hans-Martin Otten Breakdown of academic impact, for papers by A. Karabelis Breakdown of academic impact, for papers by G. A. T. Hawson Breakdown of academic impact, for papers by Claudia Parolini Breakdown of academic impact, for papers by Lee Chun Park Breakdown of academic impact, for papers by G. Lukina
Rankless by CCL
2026